CDC Corporation 

(Public, NASDAQ:CHINA)   Watch this stock   
Find more results for CHINA
Nov 23, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 23, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 4.17% -27.69%
Operating margin 3.99% -20.37%
EBITD margin - -15.39%
Return on average assets 2.48% -15.65%
Return on average equity 5.26% -37.34%
Employees 554 -

Address

33/F, Citicorp Centre 18 Whitfield Road
Causeway Bay,
Hong Kong
+1-212-6612160 (Phone)
+1-973-5919976 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Transcripts - SeekingAlpha

CDC Corporation discussed on blogs

CIENCIASMEDICASNEWS: HPAI in Backyard Chickens, Bangladesh | CDC EID - salud equitativa - CIENCIASMEDICASNEWS - 6 hours ago
Ranking 147 Chinese ADRs by Price Momentum - China Analyst - News ... - Investor's Resources - China Analyst - News and Research on US-Listed Chinese Stocks - 10 hours ago
Stock Market Analysis: Stocks to Buy 11/24/09 November 24, 2009 - stockstobuy.org - Stock Market Analysis - Nov 23, 2009

CDC Corporation discussions

  View all discussions »

Description

CDC Corporation is a global enterprise software and new media company with facilities in the People’s Republic of China, North America, Europe and Australia. The Company offer products and services to the customers in Hong Kong, Taiwan, the People’s Republic of China and other parts of Asia, Australia, New Zealand, North America, South America, the United Kingdom, and the rest of Europe. The Company operates in four business segments: software, global services, CDC games and China.com. In March 2008, the Company completed the acquisition of 51% interest in ISL Technologies Limited. In July 2008, the Company completed the acquisition of Dynamic Business Consultants Pty Limited.

Officers and directors

Kuo Fung Ch'ien Ph.D.
Chairman of the Board
Age: 57
Bio & Compensation - Reuters
Peter Yip
Vice Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation - Reuters
Matthew S. Lavelle
Chief Financial Officer
Age: 43
Bio & Compensation - Reuters
Loren B. Wimpfheimer
Senior Vice President - Mergers and Acquisitions, Acting General Counsel
Age: 47
Bio & Compensation - Reuters
Sammy Cheng
Vice President - Finance
Bio & Compensation - Reuters
Matt Wynn
Vice President, Treasurer
Bio & Compensation - Reuters
Monish Bahl
Vice President - Investor Relations and Corporate Communications
Bio & Compensation - Reuters
Donald L. Novajosky
Vice President, Associate General Counsel
Age: 38
Bio & Compensation - Reuters
Gregor Morela CPA
Chief Accounting Officer
Bio & Compensation - Reuters
Thomas M. Britt III
Independent Director
Age: 48
Bio & Compensation - Reuters